Measles

February 23 is National Kids and Vaccines Day

Retrieved on: 
Tuesday, February 7, 2023
Public Health Ontario, Caregiver, Organization, Canadian Medical Association, Science, Infection, CHC, Vaccine, HPV, Vaccination, Safety, Measles, Parent, The Honourable, Meningococcal vaccine, Health care, Public health, ScienceUpFirst, Public, COVID-19, Social media, National Kid, Hepatitis B, Pharmaceutical industry, Child

TORONTO, Feb. 7, 2023 /CNW/ - Building on the success of the first Kids and Vaccines Day in 2022, Children's Healthcare Canada (CHC) and ScienceUpFirst have declared February 23, 2023 as National Kids and Vaccines Day 2023.

Key Points: 
  • TORONTO, Feb. 7, 2023 /CNW/ - Building on the success of the first Kids and Vaccines Day in 2022, Children's Healthcare Canada (CHC) and ScienceUpFirst have declared February 23, 2023 as National Kids and Vaccines Day 2023.
  • To bring attention to the day, ScienceUpFirst and Children's Healthcare Canada will host a free national Kids and Vaccines Town Hall event on Thursday, February 23 at 5 pm pst/8 pm est/9 pm ast.
  • "Congratulations, Children's Healthcare Canada and ScienceUpFirst in delivering the second National Kids and Vaccines Day to promote the importance of routine vaccination.
  • "Children's Healthcare Canada is proud to partner with ScienceUpFirst to host the second annual National Kids and Vaccines Day, on February 23, 2023.

Americaneagle.com Announces Launch of Customer Portal and Updated Website for At-Home Antibody Test Panel Company, ImmunoProfile

Retrieved on: 
Thursday, February 2, 2023
Cold medicine, Chickenpox, Infection, World Health Organization, API, Patient, Mumps, Health, Measles, Risk, Hepatitis A, Diphtheria, WHO, Rubella, Partnership, Tetanus, Social media, Online shopping, Vaccine

First, Americaneagle.com designed the website with a secure and confidential customer portal for purchasing ImmunoProfile's products.

Key Points: 
  • First, Americaneagle.com designed the website with a secure and confidential customer portal for purchasing ImmunoProfile's products.
  • Second, the customer portal manages multiple logistical processes including those required for medical diagnostic testing in a CLIA/CAP-certified testing laboratory and the secure delivery of the customer's confidential test results.
  • ImmunoProfile offers the first-ever at-home collection Serology Antibody Test Panel for 11 common infectious diseases.
  • The test is engineered to determine personal levels of antibody protection against multiple infectious diseases in one test panel.

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Retrieved on: 
Thursday, February 2, 2023
Bank statement, D&O, Hand, CE, Physician, United Kingdom, Virus, PCR, RSV, Patient, Mpox, Artificial intelligence, Clinical trial, Measles, Letter, Risk, Hepatitis B, Immune system, Form 6-K, Antibody, Growth, Infection, Machine learning, Prevalence, COVID-19, European, PIPE, Vaccine, Cytomegalovirus, Malaria

LONDON, Feb. 2, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has issued a letter to shareholders.

Key Points: 
  • LONDON, Feb. 2, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has issued a letter to shareholders.
  • The Virax Immune platform is expected to provide a unique and actionable assessment of an individual's immunity that is both accurate and affordable.
  • In October 2022, we announced the initiation of an analytical performance study to optimize the Virax Immune T-Cell kit.
  • As you can see, expectations are high for Virax Biolabs, and we are committed to exceeding those expectations over the next year.

AS HUNGER RATES SOAR, NEW FORECAST WARNS HORN OF AFRICA FACES POTENTIAL SIXTH FAILED RAINY SEASON

Retrieved on: 
Thursday, February 2, 2023
Health, Sanitation, Hunger, Diarrhea, Food security, Measles, Temporary Emergency Food Assistance Program, Hygiene, Malnutrition, F-100 and F-75 (foods), Action Against Hunger, Water, Horn, Nutrition, Cholera, Food, Famine, Research, Agriculture

Mogadishu, Somalia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Action Against Hunger is raising the alarm about rising hunger rates as a new Climate Hazards Center forecast predicts a sixth consecutive failed rainy season in the Horn of Africa.

Key Points: 
  • Mogadishu, Somalia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Action Against Hunger is raising the alarm about rising hunger rates as a new Climate Hazards Center forecast predicts a sixth consecutive failed rainy season in the Horn of Africa.
  • “This is the worst drought the Horn of Africa has seen in 40 years.
  • “In Action Against Hunger’s 30 years in Somalia, we’ve never seen more people streaming into our hunger treatment centers.
  • “The climate crisis is a hunger crisis, and a sixth failed rainy season would bring devastation beyond words,” said Dr. Charles Owubah, CEO of Action Against Hunger.

InventHelp Inventor Develops a Quick and Easy Way to Access Multiple Drill Bits (LJD-219)

Retrieved on: 
Monday, December 19, 2022
COVID-19, Measles, Tuberculosis, Multimedia, College Point, Meningitis, Infection, DEPT, Sale, Frustration, Pharmaceutical industry

THE PILL would eliminate masks from continually being lost or forgotten at home or in vehicles and the expense associated with replacing them.

Key Points: 
  • THE PILL would eliminate masks from continually being lost or forgotten at home or in vehicles and the expense associated with replacing them.
  • May also reduce the spread of various communicable diseases such as COVID-19, measles, meningitis, tuberculosis, flu, etc.
  • The original design was submitted to the Long Island, NY sales office of InventHelp.
  • 21-LJD-219, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Vaccine R&D Leader Kathrin Jansen and Immunologist Kizzmekia Corbett Awarded Sabin’s Gold Medal and Rising Star Respectively

Retrieved on: 
Wednesday, December 7, 2022
Fever Dream, Gold medal, Rising Star, RSV, Friends, Respiratory syncytial virus, Mumps, R, Head, Merck & Co., Coronavirus, BioNTech, Gold, Mentorship, Health, Sabin, Partnership, Inbar Lavi, FDA, DRS, Rotavirus, Pfizer, Public health, Ecosystem, HPV, Harvard T.H. Chan School of Public Health, Vaccine, Degenerative disease, Doctor of Philosophy, Sabin Vaccine Institute, Streptococcus pneumoniae, Education, STEM, RNA transfection, Infection, Pneumonia, Measles, Research, Cervical cancer, Rubella, Pandemic, Rising Star Award, COVID-19, Policy, Pharmaceutical industry

WASHINGTON, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today honored two extraordinary scientists for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives. The 2022 Albert B. Sabin Gold Medal was awarded to vaccine research leader Kathrin U. Jansen, PhD, and the Rising Star to immunologist Kizzmekia Corbett, PhD.

Key Points: 
  • The 2022 Albert B. Sabin Gold Medal was awarded to vaccine research leader Kathrin U. Jansen, PhD, and the Rising Star to immunologist Kizzmekia Corbett, PhD.
  • This past August, Dr. Jansen retired as the senior vice president and head of vaccine research and development at Pfizer Inc.
  • Previously, she directed vaccine R&D efforts at Merck Research Laboratories and led the development of the world’s first cervical cancer vaccine.
  • “Her contributions to vaccine development are matched only by her dedication to shoring up vaccine confidence, especially among skeptics.

InventHelp Inventor Develops a Quick and Easy Way to Access Multiple Drill Bits (LJD-219)

Retrieved on: 
Thursday, December 8, 2022
Frustration, DEPT, College Point, Meningitis, Infection, Sale, Measles, Tuberculosis, COVID-19, Multimedia, Pharmaceutical industry

THE PILL would eliminate masks from continually being lost or forgotten at home or in vehicles and the expense associated with replacing them.

Key Points: 
  • THE PILL would eliminate masks from continually being lost or forgotten at home or in vehicles and the expense associated with replacing them.
  • May also reduce the spread of various communicable diseases such as COVID-19, measles, meningitis, tuberculosis, flu, etc.
  • The original design was submitted to the Long Island, NY sales office of InventHelp.
  • 21-LJD-219, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

STATEMENT FROM MARCH OF DIMES ON MEASLES OUTBREAK IN OHIO

Retrieved on: 
Tuesday, December 6, 2022
Vaccination, Vaccine, Federation, Pregnancy, Woman, Infection, Measles, Trustee, Research, MMR, Contagious disease, Family, COVID-19, Preterm birth, Immunity, Multimedia, Thought, Education, Health, Legislation, Risk, Pharmaceutical industry, Dime

ARLINGTON, Va., Dec. 6, 2022 /PRNewswire/ -- March of Dimes is concerned about the dangerous measles outbreak in Ohio, where health officials report a spike in cases among unvaccinated children the majority of whom are children two years old or younger.

Key Points: 
  • ARLINGTON, Va., Dec. 6, 2022 /PRNewswire/ -- March of Dimes is concerned about the dangerous measles outbreak in Ohio, where health officials report a spike in cases among unvaccinated children the majority of whom are children two years old or younger.
  • March of Dimes encourages all families to vaccinate their children against measles and other vaccine-preventable illnesses.
  • Pregnant women who contract measles are at risk for more severe complications of the illness, as well as at increased risk for preterm birth.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/statement-from-march-of-dimes-o...
    SOURCE March of Dimes Inc.

Travel Vaccine Global Market Report 2022: Stringent Advisories and Regulations by Health Authorities to Aid Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Other Travel, Pharmaceutical, Health, Travel, Sissel v. United States Department of Health & Human Services, COVID-19, Growth, Rotavirus, Typhoid fever, International Certificate of Vaccination or Prophylaxis, Human services, National Health Service, Health, Vaccine, Infection, Tetanus, Hepatitis B, Antibody, Hepatitis A, Fever Dream, Shingles, Tourism, Yellow fever, Travel, Cholera, Meningitis, Diphtheria, Disease, Spiritualism, Vaccination, Rubella, Mumps, Measles, Polio, Composition, Chickenpox, NHS, DPT, Rabies

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.

Key Points: 
  • The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.
  • The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector.
  • Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses.
  • Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

Pediatric Vaccines Global Markets Report 2022: Impacts of COVID-19, Market Revenue Data for 2020 and 2021, Estimates for 2022, and CAGR Projections through 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022
COVID-19, Consumer, Health, Pharmaceutical, Children, BCG, Investment, Incidence, Pfizer–BioNTech COVID-19 vaccine, CoronaVac, China National Pharmaceutical Group, Chickenpox, Pfizer, Vaccine, WHO, Dros, GlaxoSmithKline, Abbott Laboratories, Whooping cough, Mumps, Gavi, Merck & Co., Hepatitis, Measles, AstraZeneca, Global health, Child, Diphtheria, Mortality, Bharat Biotech, Vaccine-preventable diseases, Organization, COVID-19, Tetanus, UNICEF, Pharmaceutical industry

This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities.

Key Points: 
  • This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities.
  • The report also covers market projections through 2027 and estimates market shares for key players, as well as pediatric vaccines by type and by application.
  • The report also discusses the impact of the COVID-19 pandemic on this market.
  • Vaccines are one of the most significant advances in global health and are the most cost-effective strategy to reduce child mortality.